These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 37380984)
1. Integrated bioinformatics analysis and experimental validation reveal ISG20 as a novel prognostic indicator expressed on M2 macrophage in glioma. Peng Y; Liu H; Wu Q; Wang L; Yu Y; Yin F; Feng C; Ren X; Liu T; Chen L; Zhu H BMC Cancer; 2023 Jun; 23(1):596. PubMed ID: 37380984 [TBL] [Abstract][Full Text] [Related]
2. Integrated bioinformatics analysis and experimental validation reveal the relationship between ALOX5AP and the prognosis and immune microenvironment in glioma. Song P; Deng H; Liu Y; Zhang M BMC Med Genomics; 2024 Aug; 17(1):218. PubMed ID: 39169376 [TBL] [Abstract][Full Text] [Related]
3. Identification of CD101 in Glioma: A Novel Prognostic Indicator Expressed on M2 Macrophages. Liu Y; Yao R; Shi Y; Liu Y; Liu H; Liu J; Guan Y; Yao Y; Chen L Front Immunol; 2022; 13():845223. PubMed ID: 35350788 [TBL] [Abstract][Full Text] [Related]
4. High expression of SIGLEC7 may promote M2-type macrophage polarization leading to adverse prognosis in glioma patients. An W; Ren C; Yuan L; Qiu Z; Wang P; Cheng Y; He Z; Han X; Li S; An Y Front Immunol; 2024; 15():1411072. PubMed ID: 39211050 [TBL] [Abstract][Full Text] [Related]
5. Siglec15 is a prognostic indicator and a potential tumor-related macrophage regulator that is involved in the suppressive immunomicroenvironment in gliomas. Wang J; Xu L; Ding Q; Li X; Wang K; Xu S; Liu B Front Immunol; 2023; 14():1065062. PubMed ID: 37325664 [TBL] [Abstract][Full Text] [Related]
6. FOSL2-mediated transcription of ISG20 induces M2 polarization of macrophages and enhances tumorigenic ability of glioblastoma cells. Du H; Sun J; Wang X; Zhao L; Liu X; Zhang C; Wang F; Wu J J Neurooncol; 2024 Sep; 169(3):659-670. PubMed ID: 39073688 [TBL] [Abstract][Full Text] [Related]
7. CLEC7A regulates M2 macrophages to suppress the immune microenvironment and implies poorer prognosis of glioma. Wang J; Li X; Wang K; Li K; Gao Y; Xu J; Peng R; Zhang X; Zhang S; Zhou Y; Xu S; Zhang J Front Immunol; 2024; 15():1361351. PubMed ID: 38846954 [TBL] [Abstract][Full Text] [Related]
8. PLEKHA4 is a novel prognostic biomarker that reshapes the tumor microenvironment in lower-grade glioma. Zhi W; Wang Y; Jiang C; Gong Y; Chen Q; Mao X; Deng W; Zhao S Front Immunol; 2023; 14():1128244. PubMed ID: 37818357 [TBL] [Abstract][Full Text] [Related]
9. ISG20 promotes local tumor immunity and contributes to poor survival in human glioma. Gao M; Lin Y; Liu X; Li Y; Zhang C; Wang Z; Wang Z; Wang Y; Guo Z Oncoimmunology; 2019; 8(2):e1534038. PubMed ID: 30713788 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive Prognostic Analysis of Immune Implication Value and Oxidative Stress Significance of NECAP2 in Low-Grade Glioma. Lu Z; Chen Y; Chen S; Zhu X; Wang C; Wang Z; Yao Q Oxid Med Cell Longev; 2022; 2022():1494520. PubMed ID: 36531205 [TBL] [Abstract][Full Text] [Related]
11. M2 macrophage marker CHI3L2 could serve as a potential prognostic and immunological biomarker in glioma by integrated single-cell and bulk RNA-Seq analysis. Qian W; Wang Q; Zhang C; Zhu J; Zhang Q; Luo C J Gene Med; 2023 Sep; 25(9):e3523. PubMed ID: 37147894 [TBL] [Abstract][Full Text] [Related]
12. KLHDC8A Expression in Association with Macrophage Infiltration and Oxidative Stress Predicts Unfavorable Prognosis for Glioma. Cheng T; Xu M; Zhang H; Lu B; Zhang X; Wang Z; Huang J Oxid Med Cell Longev; 2022; 2022():2694377. PubMed ID: 36199422 [TBL] [Abstract][Full Text] [Related]
13. IL4I1 in M2-like macrophage promotes glioma progression and is a promising target for immunotherapy. Ye F; Wang L; Li Y; Dong C; Zhou L; Xu J Front Immunol; 2023; 14():1338244. PubMed ID: 38250074 [TBL] [Abstract][Full Text] [Related]
14. Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in Glioma. Zeng F; Li G; Liu X; Zhang K; Huang H; Jiang T; Zhang Y Oncologist; 2021 Aug; 26(8):e1460-e1469. PubMed ID: 33687124 [TBL] [Abstract][Full Text] [Related]
15. PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas. Zhang H; He J; Dai Z; Wang Z; Liang X; He F; Xia Z; Feng S; Cao H; Zhang L; Cheng Q Front Immunol; 2021; 12():628966. PubMed ID: 33664747 [TBL] [Abstract][Full Text] [Related]
16. GPR37 expression as a prognostic marker in gliomas: a bioinformatics-based analysis. Liang K; Guo Z; Zhang S; Chen D; Zou R; Weng Y; Peng C; Xu Z; Zhang J; Liu X; Pang X; Ji Y; Liao D; Lai M; Peng H; Ke Y; Wang Z; Wang Y Aging (Albany NY); 2023 Oct; 15(19):10146-10167. PubMed ID: 37837549 [TBL] [Abstract][Full Text] [Related]
17. High expression of ISG20 predicts a poor prognosis in acute myeloid leukemia. Xiong H; Zhang X; Chen X; Liu Y; Duan J; Huang C Cancer Biomark; 2021; 31(3):255-261. PubMed ID: 33896836 [TBL] [Abstract][Full Text] [Related]
18. Elevated expression of DOK3 indicates high suppressive immune cell infiltration and unfavorable prognosis of gliomas. Liu X; Chen F; Li W Int Immunopharmacol; 2020 Jun; 83():106400. PubMed ID: 32193105 [TBL] [Abstract][Full Text] [Related]
19. Matrix Remodeling-Associated Protein 8 as a Novel Indicator Contributing to Glioma Immune Response by Regulating Ferroptosis. Xu Z; Chen X; Song L; Yuan F; Yan Y Front Immunol; 2022; 13():834595. PubMed ID: 35281049 [TBL] [Abstract][Full Text] [Related]